11/16
08:06 am
dmac
We're Not Very Worried About DiaMedica Therapeutics' (NASDAQ:DMAC) Cash Burn Rate [Yahoo! Finance]
Medium
Report
We're Not Very Worried About DiaMedica Therapeutics' (NASDAQ:DMAC) Cash Burn Rate [Yahoo! Finance]
11/15
08:04 am
dmac
DiaMedica Therapeutics Inc. (NASDAQ: DMAC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $7.00 price target on the stock.
Medium
Report
DiaMedica Therapeutics Inc. (NASDAQ: DMAC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $7.00 price target on the stock.
11/13
04:47 pm
dmac
DiaMedica Therapeutics GAAP EPS of -$0.15 in-line [Seeking Alpha]
Low
Report
DiaMedica Therapeutics GAAP EPS of -$0.15 in-line [Seeking Alpha]
11/13
04:26 pm
dmac
DiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2024 Financial Results [Yahoo! Finance]
Low
Report
DiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2024 Financial Results [Yahoo! Finance]
11/13
04:20 pm
dmac
DiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2024 Financial Results
Low
Report
DiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2024 Financial Results
11/13
04:05 pm
dmac
DiaMedica Therapeutics Announces Dosing of First Patient in Phase 2 Trial of DM199 in the Treatment of Preeclampsia
Medium
Report
DiaMedica Therapeutics Announces Dosing of First Patient in Phase 2 Trial of DM199 in the Treatment of Preeclampsia
11/12
08:28 am
dmac
DiaMedica Therapeutics to Participate in Upcoming Craig-Hallum 15th Annual Alpha Select Conference [Yahoo! Finance]
Low
Report
DiaMedica Therapeutics to Participate in Upcoming Craig-Hallum 15th Annual Alpha Select Conference [Yahoo! Finance]
11/12
08:23 am
dmac
DiaMedica Therapeutics to Participate in Upcoming Craig-Hallum 15th Annual Alpha Select Conference
Low
Report
DiaMedica Therapeutics to Participate in Upcoming Craig-Hallum 15th Annual Alpha Select Conference
11/6
08:53 am
dmac
DiaMedica Therapeutics to Provide a Business Update and Report Third Quarter 2024 Financial Results November 14, 2024 [Yahoo! Finance]
Low
Report
DiaMedica Therapeutics to Provide a Business Update and Report Third Quarter 2024 Financial Results November 14, 2024 [Yahoo! Finance]
11/6
08:32 am
dmac
DiaMedica Therapeutics to Provide a Business Update and Report Third Quarter 2024 Financial Results November 14, 2024
Low
Report
DiaMedica Therapeutics to Provide a Business Update and Report Third Quarter 2024 Financial Results November 14, 2024
10/9
08:31 am
dmac
DiaMedica Therapeutics Announces Regulatory Approval to Begin Phase 2 Trial of DM199 in the Treatment of Preeclampsia [Yahoo! Finance]
Medium
Report
DiaMedica Therapeutics Announces Regulatory Approval to Begin Phase 2 Trial of DM199 in the Treatment of Preeclampsia [Yahoo! Finance]
10/9
08:27 am
dmac
DiaMedica Therapeutics Announces Regulatory Approval to Begin Phase 2 Trial of DM199 in the Treatment of Preeclampsia
Low
Report
DiaMedica Therapeutics Announces Regulatory Approval to Begin Phase 2 Trial of DM199 in the Treatment of Preeclampsia
10/8
06:56 am
dmac
DiaMedica Therapeutics Insiders Placed Bullish Bets Worth US$9.05m [Yahoo! Finance]
Medium
Report
DiaMedica Therapeutics Insiders Placed Bullish Bets Worth US$9.05m [Yahoo! Finance]
10/7
08:10 am
dmac
DiaMedica Therapeutics Inc. (NASDAQ: DMAC) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $7.00 price target on the stock.
Medium
Report
DiaMedica Therapeutics Inc. (NASDAQ: DMAC) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $7.00 price target on the stock.
9/4
04:15 pm
dmac
DiaMedica Therapeutics Upcoming Conference Participation
Low
Report
DiaMedica Therapeutics Upcoming Conference Participation